Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Harvard Business School
Johnson and Johnson
QuintilesIMS
Covington
US Army
Chinese Patent Office
Daiichi Sankyo
Moodys
Deloitte

Generated: August 19, 2017

DrugPatentWatch Database Preview

GALANTAMINE HYDROBROMIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Galantamine Hydrobromide, and what generic Galantamine Hydrobromide alternatives are available?

Galantamine Hydrobromide is a drug marketed by Mylan, Yabao Pharm, Barr, West-ward Pharms Int, Watson Labs, Aurobindo Pharma Ltd, Sun Pharma Global, Apotex Inc, Impax Labs, Actavis Elizabeth, Teva Pharms, Sandoz, Dr Reddys Labs Ltd, and Zydus Pharms Usa Inc. and is included in nineteen NDAs.

The generic ingredient in GALANTAMINE HYDROBROMIDE is galantamine hydrobromide. There are fifteen drug master file entries for this compound. Twenty suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the galantamine hydrobromide profile page.

Summary for Tradename: GALANTAMINE HYDROBROMIDE

Patents:0
Applicants:14
NDAs:19
Suppliers / Packagers: see list15
Bulk Api Vendors: see list53
Clinical Trials: see list147
Patent Applications: see list351
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GALANTAMINE HYDROBROMIDE at DailyMed

Pharmacology for Tradename: GALANTAMINE HYDROBROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
GALANTAMINE HYDROBROMIDE
galantamine hydrobromide
TABLET;ORAL077589-001Jun 22, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
GALANTAMINE HYDROBROMIDE
galantamine hydrobromide
TABLET;ORAL077585-001Sep 15, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
GALANTAMINE HYDROBROMIDE
galantamine hydrobromide
TABLET;ORAL077593-003Sep 11, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
GALANTAMINE HYDROBROMIDE
galantamine hydrobromide
TABLET;ORAL077590-002May 29, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
GALANTAMINE HYDROBROMIDE
galantamine hydrobromide
CAPSULE, EXTENDED RELEASE;ORAL204895-001Aug 5, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
UBS
QuintilesIMS
Federal Trade Commission
Novartis
Teva
Baxter
Julphar
Merck
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot